RDUS Radius Health, Inc.

+0.49  (1.09%)
Previous Close 45.16
Open 45.13
Price To book 5.52
Market Cap 1.97B
Shares 43,111,000
Volume 400,186
Short Ratio 9.74
Av. Daily Volume 762,798

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

PDUFA March 30 2017

Latest News

  1. Radius Health (RDUS) Q4 Earnings: Will the Stock Disappoint?
  2. Mayo Clinic Proceedings Publishes Positive Results from the ACTIVExtend Clinical Trial of Abaloparatide-SC in Postmenopausal Women With Osteoporosis
  3. Radius Health to Announce Fourth Quarter and Full Year 2016 Financial Results, Host Conference Call and Live Webcast on February 23, 2017
  4. Radius Health to Present at the 35th Annual J.P. Morgan Healthcare Conference
  5. Here's Why Radius Health Dropped 12% Today Despite Positive Clinical Results
  6. Radius Presents Positive Phase I Data for Investigational Drug RAD1901 at the San Antonio Breast Cancer Symposium (SABCS) 2016
  7. Radius Health, Inc. :RDUS-US: Earnings Analysis: Q3, 2016 By the Numbers : November 28, 2016
  8. Hedge Funds Are Betting On Radius Health Inc (RDUS)
  9. RADIUS HEALTH, INC. Financials
  10. Edited Transcript of RDUS earnings conference call or presentation 3-Nov-16 12:00pm GMT
  11. Radius Health (RDUS) Q3 Loss Match Estimates, Wider Y/Y
  12. Radius Health (RDUS) Q3 Loss in Line with Estimates
  13. RADIUS HEALTH, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib
  14. Radius Health Reports Third Quarter 2016 Financial and Operating Results
  15. Radius Health (RDUS): Will It Disappoint in Q3 Earnings?
  16. Pardon Me, but I Have a Few Things to Say... Trump, Bernie, Radius, Ariad
  17. Radius Health to Announce Third Quarter 2016 Financial Results, Host Conference Call and Live Webcast on November 3, 2016
  18. Jim Cramer's Top Takeaways: Nike, Newell Brands, Paychex, Radius Health
  19. Volatility Set To Rise
  20. Romosozumab From Amgen Inc (AMGN) Shows Positive Results In Osteoporosis